Organigram Global Inc. Q3 Results: Net revenue rises 49% YoY
Organigram Global Inc. reported Q3 ended June 30, 2026 net revenue of $105.8 million, up 49% from $70.8 million, and adjusted EBITDA of $13.4 million, up from $5.7 million. Net income swung to $105.5 million from a $6.3 million loss, helped by non-cash preferred share fair value gains. The company cited Sanity Group integration and guided FY2026 net revenue above $350 million.
How this was made
The 30-second read
Why it matters
The quarter shows strong top-line and adjusted profitability growth, but cash flow conversion deteriorated due to working-capital investment, creating a key debate for traders: earnings quality versus liquidity trajectory.
Market read
A company-specific earnings release with detailed revenue, EBITDA, margin, and cash-flow metrics plus leadership change and integration updates.
What to watch
Free cash flow was negative ($-3.9M) despite improved operating cash before working capital, implying liquidity and working-capital intensity could cap the multiple if it persists.
Background
Organigram says its Q3 performance reflects operational integration after acquiring Sanity Group GmbH, plus international sales mix and efficiency gains.
Ticker impact
Organigram (OGI) reported Q3 net revenue of $105.8M (+49% YoY) and adjusted EBITDA of $13.4M (+136%), citing Sanity Group integration impact.
Near-term bias positive on revenue and EBITDA beats, with follow-through dependent on whether working-capital drag eases in coming quarters.
The article provides multiple primary financial datapoints (revenue, EBITDA, margins, cash flow) and links them to the Sanity acquisition, which is a concrete catalyst for re-rating expectations.
Market effects
Cannabis peers may see read-across on integration execution and international mix improving margins, but cash conversion remains a key watch item.
Canadian cannabis operators with European distribution ambitions could benefit from investor appetite if integration milestones translate into sustained profitability.
Limited, as the article is company-specific and does not introduce new regulatory or macro shocks for the broader cannabis market.
Counterpoint
The large net income jump is attributed mainly to non-cash fair value gains on preferred shares, so core cash earnings quality may be overstated.
Key entities
- companyOrganigram Global Inc.
Canadian cannabis company reporting Q3 FY26 results and integration progress after acquiring Sanity Group.
- companySanity Group GmbH
European cannabis operator whose integration is credited with revenue contribution and margin improvement.
- personPaolo De Luca
Departing CFO and Chief Strategy Officer after nine years, with Greg Guyatt succeeding as CFO.
- personGreg Guyatt
Incoming CFO who reiterated full-year FY26 net revenue and profitability expectations.
